HK1124529A1 - Formulation having accurate dose-dividing function - Google Patents

Formulation having accurate dose-dividing function

Info

Publication number
HK1124529A1
HK1124529A1 HK09102104A HK09102104A HK1124529A1 HK 1124529 A1 HK1124529 A1 HK 1124529A1 HK 09102104 A HK09102104 A HK 09102104A HK 09102104 A HK09102104 A HK 09102104A HK 1124529 A1 HK1124529 A1 HK 1124529A1
Authority
HK
Hong Kong
Prior art keywords
formulation
dividing function
accurate dose
dose
accurate
Prior art date
Application number
HK09102104A
Other languages
English (en)
Inventor
Masahiko Narasaki
Tomoya Akutagawa
Reiko Oku
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Publication of HK1124529A1 publication Critical patent/HK1124529A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
HK09102104A 2005-08-18 2009-03-04 Formulation having accurate dose-dividing function HK1124529A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005237369 2005-08-18
PCT/JP2006/316542 WO2007021032A1 (fr) 2005-08-18 2006-08-17 Préparation avec fonction de division en doses précises

Publications (1)

Publication Number Publication Date
HK1124529A1 true HK1124529A1 (en) 2009-07-17

Family

ID=37757676

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09102104A HK1124529A1 (en) 2005-08-18 2009-03-04 Formulation having accurate dose-dividing function
HK11107378A HK1153120A1 (en) 2005-08-18 2011-07-15 Preparation with accurate dose-dividing function

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK11107378A HK1153120A1 (en) 2005-08-18 2011-07-15 Preparation with accurate dose-dividing function

Country Status (10)

Country Link
US (1) US9028867B2 (fr)
EP (2) EP1915989A4 (fr)
JP (2) JP5059611B2 (fr)
KR (1) KR20080034517A (fr)
CN (2) CN101291656B (fr)
AU (1) AU2006280656B2 (fr)
CA (1) CA2619744C (fr)
HK (2) HK1124529A1 (fr)
TW (1) TWI415632B (fr)
WO (1) WO2007021032A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2928836B1 (fr) * 2008-03-21 2011-08-26 Servier Lab Forme galenique secable permettant une liberation modifiee du principe actif
US20100255082A1 (en) * 2008-07-31 2010-10-07 Ishwar Chauhan Functionally Coated Breakable Tablets
CN101658505A (zh) * 2009-09-29 2010-03-03 北京华禧联合科技发展有限公司 非布索坦的缓释制剂及其制备方法
WO2011158870A1 (fr) * 2010-06-16 2011-12-22 帝人ファーマ株式会社 Comprimé nucléé à libération contrôlée
MY160963A (en) * 2010-06-25 2017-03-31 Teijin Pharma Ltd Sustained-release therapeutic agent for hypertension and renal dysfunction
JP5986984B2 (ja) * 2011-03-03 2016-09-06 武田薬品工業株式会社 積層錠剤、その製造方法、および、層剥離抑制方法
WO2014013973A1 (fr) * 2012-07-19 2014-01-23 大塚製薬株式会社 Machine à imprimer et comprimé associé
JP2017040636A (ja) * 2015-08-19 2017-02-23 日東精工株式会社 粉末圧縮成形機用杵の検査装置
CN108663441B (zh) * 2017-12-30 2021-03-30 南京海融制药有限公司 一种他卡西醇软膏剂有关物质检查方法
CN111407734A (zh) * 2019-01-05 2020-07-14 厦门赛诺邦格生物科技股份有限公司 一种阳痿早泄治疗药物的固体制剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5331211B2 (fr) * 1972-09-28 1978-09-01
US4258027A (en) * 1979-03-26 1981-03-24 Mead Johnson & Company Multi-fractionable tablet structure
US4215104A (en) * 1979-03-26 1980-07-29 Mead Johnson & Company Multi-fractionable tablet structure
JPS6017099A (ja) 1983-07-08 1985-01-28 Kawasaki Steel Corp 電気抵抗溶接用表面処理鋼板の製造方法
DE69228457T2 (de) * 1991-09-10 1999-06-17 Takeda Chemical Industries Ltd Teilbare Tablette
JPH069375A (ja) 1992-04-10 1994-01-18 Takeda Chem Ind Ltd 分割可能な連結錠剤
US5322655A (en) * 1993-02-19 1994-06-21 Thomas Engineering, Inc. Method for monitoring and controlling the weights of each layer of a multilayer tablet
JP3015677B2 (ja) 1994-08-10 2000-03-06 ファイザー製薬株式会社 フィルムコーティングを施した分割錠剤
JPH0950126A (ja) 1995-08-08 1997-02-18 Fujitsu Ltd レジスト組成物及びレジストパターン形成方法
JP3880093B2 (ja) 1995-08-08 2007-02-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 錠剤
JP3572871B2 (ja) 1997-06-10 2004-10-06 日本新薬株式会社 分割錠
BR9814645A (pt) 1997-11-18 2001-07-31 Teijin Ltd Derivados de amina cìclica e seu uso como medicamentos
ID24846A (id) 1997-11-20 2000-08-24 Teijin Ltd Turunan-turunan bifenilamidina
US6602521B1 (en) 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
JP2001072579A (ja) 1999-06-29 2001-03-21 Taisho Pharmaceut Co Ltd 有核錠及びその製造方法並びに製造システム
JP2001129693A (ja) * 1999-10-28 2001-05-15 Lion Corp 錠剤及びその製造方法
CN1198819C (zh) 2000-01-17 2005-04-27 帝人株式会社 苯并咪唑衍生物
ES2379729T3 (es) * 2000-06-20 2012-05-03 Sanwa Kagaku Kenkyusho Co., Ltd. Método para producir una pieza moldeada con núcleo
EP1302304B1 (fr) 2000-06-20 2011-12-14 Sanwa Kagaku Kenkyusho Co., Ltd. Procede de production d'un article moulé a noyau
CN1255265C (zh) * 2001-08-30 2006-05-10 株式会社三和化学研究所 用于制造成型品的装置和使用该装置制造成型品的方法
DK1437116T3 (da) 2001-09-26 2009-04-20 Sanwa Kagaku Kenkyusho Co Fremgangsmåde til fremstilling af en stöbeformet genstand med flere kerner og indretning til fremstilling af samme
CN1606434A (zh) 2001-12-19 2005-04-13 株式会社三和化学研究所 控制释放成型品
JP4652662B2 (ja) 2002-12-13 2011-03-16 田辺三菱製薬株式会社 分割錠剤
AU2005245026B2 (en) * 2004-05-21 2010-07-01 Accu-Break Technologies, Inc. Immediate release pharmaceutical tablets with height greater than width

Also Published As

Publication number Publication date
EP1915989A4 (fr) 2012-05-30
AU2006280656A1 (en) 2007-02-22
JP2011173932A (ja) 2011-09-08
CA2619744C (fr) 2014-09-02
JP5336553B2 (ja) 2013-11-06
WO2007021032A1 (fr) 2007-02-22
HK1153120A1 (en) 2012-03-23
US20090110726A1 (en) 2009-04-30
US9028867B2 (en) 2015-05-12
TWI415632B (zh) 2013-11-21
CA2619744A1 (fr) 2007-02-22
CN102008392B (zh) 2013-07-31
JPWO2007021032A1 (ja) 2009-02-26
EP3205337A1 (fr) 2017-08-16
EP1915989A1 (fr) 2008-04-30
KR20080034517A (ko) 2008-04-21
CN101291656A (zh) 2008-10-22
AU2006280656B2 (en) 2012-09-20
JP5059611B2 (ja) 2012-10-24
CN102008392A (zh) 2011-04-13
TW200800297A (en) 2008-01-01
CN101291656B (zh) 2012-11-07

Similar Documents

Publication Publication Date Title
IL189856A0 (en) New formulation
PL1879451T3 (pl) Innowacyjna formulacja
TWI370115B (en) New formulation
GB2424581B (en) Formulations
IL191287A0 (en) Atorvastatin formulation
GB0526419D0 (en) Formulation
EP1909584A4 (fr) Formulations a base de prenylflavonoides
HK1124529A1 (en) Formulation having accurate dose-dividing function
GB0507208D0 (en) Anti-inflammatory formulation
GB0517673D0 (en) Formulation
GB0428165D0 (en) Position measurement
IL185773A0 (en) Formulations
EP1928469A4 (fr) Formulation de fulvestrant
GB0621895D0 (en) Calibration standard
GB0423565D0 (en) Formulation
PL1855661T3 (pl) Preparaty zawierające awiptadil
GB0412530D0 (en) Formulation
GB0501030D0 (en) Formulation
PL1928232T3 (pl) Stała formulacja
ZA200803086B (en) Bisphosphonate formulation
GB2427472B (en) Calibration standard
IL166575A0 (en) Rangefinder
PT1855661E (pt) Formulações para aviptadil
GB0506035D0 (en) Improved formulation
GB0518952D0 (en) Bisphosphonate formulation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160817